ERD

From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatiti...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Application of long single-stranded DNA donors in genome editing: generation and validation of mouse mutants

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Hepatocellular carcinoma and metabolic risk factors in a main reference center in Italy

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

The impact of human activities and lifestyles on the interlinked microbiota and health of humans and of ecosystems

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Non-pharmacological interventions in non-alcoholic fatty liver disease patients

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

NASH in Lean Individuals

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Metabolic Modeling of Human Gut Microbiota on a Genome Scale: An Overview

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Risk assessment procedure

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Plasma Selenoprotein P levels are related to adipose tissue insulin resistance, composition of free fatty acids and live...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Insulin secretion and decreased glucose clearance are associated with enhanced fibrogenesis and a high risk of disease p...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Report on data management plan for the EPoS project

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Project Handbook

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Heterogeneity of non-alcoholic fatty liver disease

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Hepatic macrophage activation is associated with adipose tissue insulin resistance in non-diabetic patients with Non-Alc...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

A spotlight on pathogenesis, interactions and novel therapeutic options in NAFLD

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

P465L-PPARγ mutation confers partial resistance to the hypolipidaemic action of fibrates

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Genetics of alcoholic liver disease and non-alcoholic steatohepatitis

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

In non obese NAFLD increased plasma saturated fatty acids and insulin resistance are metabolic signatures of severity of...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Assessment of liver fibrosis progression and regression by a serological collagen turnover profile

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Liver fibrosis: Direct antifibrotic agents and targeted therapies

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Fibrosis and alcohol-related liver disease

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Predisposition to diabetes is related to insulin resistance in NAFLD patients and to decreased insulin secretion in HCV ...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatit...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Phosphatidylglycerols are induced by gut dysbiosis and inflammation, and favorably modulate adipose tissue remodeling in...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters ...

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program

Project: EPoS

Updated at: 29-04-2024

Show more information

Project acronym EPoS

Resources

Selected filters:

From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options

Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatiti...

Application of long single-stranded DNA donors in genome editing: generation and validation of mouse mutants

Hepatocellular carcinoma and metabolic risk factors in a main reference center in Italy

The impact of human activities and lifestyles on the interlinked microbiota and health of humans and of ecosystems

Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study

Non-pharmacological interventions in non-alcoholic fatty liver disease patients

NASH in Lean Individuals

Metabolic Modeling of Human Gut Microbiota on a Genome Scale: An Overview

Risk assessment procedure

Plasma Selenoprotein P levels are related to adipose tissue insulin resistance, composition of free fatty acids and live...

Insulin secretion and decreased glucose clearance are associated with enhanced fibrogenesis and a high risk of disease p...

Report on data management plan for the EPoS project

Project Handbook

Heterogeneity of non-alcoholic fatty liver disease

Hepatic macrophage activation is associated with adipose tissue insulin resistance in non-diabetic patients with Non-Alc...

A spotlight on pathogenesis, interactions and novel therapeutic options in NAFLD

P465L-PPARγ mutation confers partial resistance to the hypolipidaemic action of fibrates

Genetics of alcoholic liver disease and non-alcoholic steatohepatitis

In non obese NAFLD increased plasma saturated fatty acids and insulin resistance are metabolic signatures of severity of...

Assessment of liver fibrosis progression and regression by a serological collagen turnover profile

The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Liver fibrosis: Direct antifibrotic agents and targeted therapies

Fibrosis and alcohol-related liver disease

Predisposition to diabetes is related to insulin resistance in NAFLD patients and to decreased insulin secretion in HCV ...

Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatit...

Phosphatidylglycerols are induced by gut dysbiosis and inflammation, and favorably modulate adipose tissue remodeling in...

Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters ...

Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease

Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program